An Innovative Care Model Integrating Mobile Health Support to Promote Weight Management in Adults With Overweight or Obesity
Launched by THE UNIVERSITY OF HONG KONG · May 20, 2025
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background: Obesity leads to cardiovascular diseases, diabetes, musculoskeletal disorders, and many types of cancers. Insufficient physical activity and unhealthy diet (including high intake of saturated fatty acids, fat and inadequate consumption of dietary fibre) are the major causes of obesity but they are preventable and reversible.
The Population Health Survey 2020-22 showed that the overall prevalence of overweight and obese (level 1 and 2) in Hong Kong is 22.0% and 32.6%, respectively. The age-standardized prevalence of physical inactivity has risen from 12.4% (crude prevalence: 13.0...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Hong Kong residents aged ≥18 years;
- • 2. able to read and communicate in Chinese;
- • 3. own a smartphone with internet access;
- • 4. have good mobility alone without gait aid;
- • 5. body mass index ≥ 23.0;
- • 6. and no contraindication for physical activity as evidenced by: If aged \< 70: do not meet any criteria in PAR-Q, or sign declaration of having medical clearance if meet any criteria in PAR-Q; If aged ≥ 70: sign the declaration about conducting physical activity frequently or having medical clearance
- Exclusion Criteria:
- • 1. Have a terminal illness (e.g., advanced cancer, dementia, pulmonary, neurological, motor-neuron, and advanced cardiovascular disease) or with a life expectancy of less than 6 months;
- • 2. currently receiving treatment for any cancer (active cancer patients) or cancer survivor of any GI cancers (e.g. colorectal cancer, stomach cancer);
- • 3. lactating, pregnant or planning for pregnancy in the coming 6 months;
- • 4. have current diagnosis of psychiatric disorder;
- • 5. have previous diagnosis of eating disorder;
- • 6. have diagnoses of gastrointestinal conditions (e.g. Irritable Bowel Syndrome, Ulcerative Colitis, Crohn's Disease, Coeliac Disease);
- • 7. currently receiving intensive diet or exercise treatment;
- • 8. have clinical obesity (e.g. confirmation of excess body fat plus limitations of day-to-day activities or signs or symptoms of obesity-related organ dysfunction). Examples of obesity-related organ dysfunction include NAFLD with hepatic fibrosis, the cluster of hyperglycaemia, high triglyceride levels, and low HDL cholesterol levels. Examples of limitations of day-to-day activities include significant age-adjusted limitations of mobility and/or other basic ADL (e.g. bathing, dressing, toileting, continence, eating).
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Siu Chee Chan Professor
Principal Investigator
he University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported